miR-378b Regulates Insulin Sensitivity by Targeting Insulin Receptor and p110α in Alcohol-Induced Hepatic Steatosis. 2020

Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
College of Pharmacy, Guilin Medical University, Guilin, China.

Insulin resistance has been implicated in alcoholic liver disease. A previous study has shown that microRNAs (miRNAs) play a major role in the production, secretion, and function of insulin. MiRNAs are capable of repressing multiple target genes that in turn negatively regulate various physiological and pathological activities. However, current information on the biological function of miRNAs in insulin resistance is limited. The goal of the present study was to elucidate the role of miR-378b in alcohol-induced hepatic insulin resistance and its underlying mechanism. This study has observed that miR-378b is up-regulated in National Institute on Alcohol Abuse and Alcoholism (NIAAA) alcoholic mouse models as well as in ethanol-induced L-02 cells in vitro. Furthermore, miR-378b overexpression impaired the insulin signaling pathway, and inhibition of miR-378b improved insulin sensitivity in vivo and in vitro. A mechanistic study revealed that IR and p110α are direct targets of miR-378b. Together, these results suggest that miR-378b controls insulin sensitivity by targeting the insulin receptor (IR) as well as p110α and possibly play an inhibitory role in the development of insulin resistance, thereby providing insights into the development of novel diagnostic and treatment methods.

UI MeSH Term Description Entries

Related Publications

Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
January 2018, Frontiers in pharmacology,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
May 2016, The American journal of pathology,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
December 2020, JHEP reports : innovation in hepatology,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
October 2018, The Journal of endocrinology,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
February 2020, EMBO reports,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
December 2014, Nature communications,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
March 2022, American journal of physiology. Regulatory, integrative and comparative physiology,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
January 2012, PloS one,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
January 2018, Frontiers in pharmacology,
Yuan-Yuan Li, and Yu-Juan Zhong, and Qi Cheng, and Ying-Zhao Wang, and Yuan-Yuan Fan, and Cheng-Fang Yang, and Zuheng Ma, and Yong-Wen Li, and Li Li
January 2021, BioMed research international,
Copied contents to your clipboard!